Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR 353.75
+19.85 (5.94%)
At close: Mar 10, 2026
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 21.67 billion as of March 10, 2026. Its market cap has increased by 5.19% in one year.
Market Cap
21.67B
Enterprise Value
21.00B
Revenue
6.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
353.75
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 21.67B, an increase of 2.81%. That is a compound annual growth rate of 0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 20.45B | -11.27% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 632.30B |
| Anthem Biosciences | 372.46B |
| OneSource Specialty Pharma | 169.70B |
| Concord Biotech | 126.29B |
| Blue Jet Healthcare | 66.84B |
| Supriya Lifescience | 50.54B |
| Zota Health Care | 40.47B |
| Dishman Carbogen Amcis | 25.75B |